Roxas, Rhoay .
HRN: 28-32-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2025
CEFUROXIME 750MG (VIAL)
12/22/2025
12/28/2025
IV
750mg
Q8
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes